$106.34
Merck & Company Inc is a drug manufacturers-general business based in the US. Merck-and-Company shares (MRK.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $106.34 – a decrease of 0.37% over the previous day. Merck-and-Company employs 67,000 staff and has a market cap (total outstanding shares value) of $270.8 billion.
How to buy shares in Merck-and-Company
- Choose a platform. If you're a beginner, our stock-dealing table below can help you choose.
- Open your account. Provide your personal information and sign up.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: MRK in this case.
- Research stocks. The platform should provide the latest information available.
- Buy your stocks. It's that simple.
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
Is it a good time to buy Merck-and-Company stock?
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Buy Merck-and-Company stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Is Merck-and-Company stock undervalued or overvalued?
Valuing Merck-and-Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merck-and-Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Merck-and-Company financials
Revenue TTM | $58.3 billion |
---|---|
Operating margin TTM | 14.87% |
Gross profit TTM | $42.1 billion |
Return on assets TTM | 5.12% |
Return on equity TTM | 7.61% |
Profit margin | 5.34% |
Book value | $15.24 |
Market capitalisation | $270.8 billion |
TTM: trailing 12 months
Merck-and-Company share dividends
Dividend payout ratio: 103.91% of net profits
Recently Merck-and-Company has paid out, on average, around 103.91% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.72% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Merck-and-Company shareholders could enjoy a 2.72% return on their shares, in the form of dividend payments. In Merck-and-Company's case, that would currently equate to about $2.84 per share.
Merck-and-Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Merck-and-Company's most recent dividend payout was on 6 October 2023. The latest dividend was paid out to all shareholders who bought their shares by 14 September 2023 (the "ex-dividend date").
Have Merck-and-Company's shares ever split?
Merck-and-Company's shares were split on a 1048:1000 basis on 3 June 2021. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1048 shares. This wouldn't directly have changed the overall worth of your Merck-and-Company shares – just the quantity. However, indirectly, the new 4.6% lower share price could have impacted the market appetite for Merck-and-Company shares which in turn could have impacted Merck-and-Company's share price.
Merck-and-Company overview
Merck & Co. , Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…
What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More guides on Finder
-
How to buy Yoshitsu Co. stock in Canada
Steps to owning and managing Yoshitsu Co. stocks, with 24-hour and historical pricing before you buy.
-
How to buy Cerberus Cyber Sentinel stock in Canada
Steps to owning and managing Cerberus Cyber Sentinel stocks, with 24-hour and historical pricing before you buy.
-
How to buy Fresh Grapes LLC stock in Canada
Steps to owning and managing Fresh Vine Wine, Inc stocks, with 24-hour and historical pricing before you buy.
-
How to buy Quest Diagnostics Incorporated stock in Canada
Steps to owning and managing DGX with 24-hour and historical pricing before you buy.
-
How to buy Nuvectis Pharma (NVCT) stock in Canada when it goes public
Everything we know about the Nuvectis Pharma IPO plus information on how to buy in.
-
How to buy BuzzFeed stock in Canada
Steps to owning and managing BuzzFeed, Inc stocks, with 24-hour and historical pricing before you buy.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
How to buy ADMA Biologics stock in Canada
Steps to owning and managing ADMA with 24-hour and historical pricing before you buy.
-
How to buy Dycom Industries stock in Canada
Steps to owning and managing DY with 24-hour and historical pricing before you buy.
-
How to buy VICI Properties stock in Canada
Steps to owning and managing VICI with 24-hour and historical pricing before you buy.